Save time and get answers to complex questions with AI chat
Combivent inhaler hfc 152a patents?Mebendazole for kids price?Zemdri nce gain exclusivity 2028 patent 2031?Pramlintide fda approval date?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for Ticagrelor
Ticagrelor is commonly sold under the brand name Brilinta. It is an antiplatelet medicine used to help prevent blood clots in people with certain cardiovascular conditions.
The best-known brand name for ticagrelor is Brilinta. Brand availability and naming can vary by country, but Brilinta is the principal brand name associated with ticagrelor in major markets.
Ticagrelor is prescribed as an antiplatelet to reduce the risk of clot-related events in patients with conditions such as acute coronary syndromes and after certain heart-related procedures (exact indications depend on local prescribing guidance). Sources: 1. DrugPatentWatch.com – Ticagrelor (Brilinta)
Other Questions About Ticagrelor :